Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer

Mark N. Adams, Joshua T. Burgess, Yaowu He, Kathy Gately, Cameron Snell, Shu-Dong Zhang, John D. Hooper, Derek J. Richard, Kenneth J. O’Byrne

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)1071-1084
JournalJournal of Thoracic Oncology
Volume12
Issue number7
DOIs
Publication statusPublished - 15 Jul 2017

Keywords

  • non-small cell lung cancer
  • CDCA3
  • cell cycle
  • senescence

Cite this